21 CFR Part 807 · Establishment Registration and Device Listing for Manufacturers and Initial Importers of Devices

§ 807.97 Misbranding by reference to premarket notification

Subpart E - Premarket Notification Procedures Official text on eCFR Amendment history

Submission of a premarket notification in accordance with this subpart, and a subsequent determination by the Commissioner that the device intended for introduction into commercial distribution is substantially equivalent to a device in commercial distribution before May 28, 1976, or is substantially equivalent to a device introduced into commercial distribution after May 28, 1976, that has subsequently been reclassified into class I or II, does not in any way denote official approval of the device. Any representation that creates an impression of official approval of a device because of complying with the premarket notification regulations is misleading and constitutes misbranding.

Independent copy, not an official legal edition. 21 CFR is a U.S. Government work in the public domain; this text comes from the eCFR and the annual CFR edition, and may lag recent amendments. The authoritative version is on ecfr.gov. Compliome is not affiliated with or endorsed by FDA. Not legal advice.

Warning letters citing § 807.97

5 FDA warning letters since 2017 cite this section :

FDA guidance that cites § 807.97

Amendment history

Federal Register documents that created or amended this section.